Zoulim, F., Fournier, C., Habersetzer, F., Sprinzl, M.F., Pol, S., Coffin, C.S., Leroy, V., Ma, M., Wedemeyer, H., Lohse, A.W., Thimme, R., Lugardon, K., Martin, P., Bastien, B., Sansas, B., Adda, N., Halluard, C., Bendjama, K., Brandely, M. und Inchauspé, G. (2023) Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1 b placebo-controlled trial [cd]. Freiburg: Universität. doi:10.1080/21645515.2019.1651141.

Zoulim, Fabien, Claire Fournier, François Habersetzer, Martin F. Sprinzl, Stanislas Pol, Carla S Coffin, Vincent Leroy, Mang Ma, Heiner Wedemeyer, Ansgar W. Lohse, Robert Thimme, Karine Lugardon, Perrine Martin, Bérangère Bastien, Benoit Sansas, Nathalie Adda, Celine Halluard, Kaïdre Bendjama, Maud Brandely, und Geneviève Inchauspé. Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1 b placebo-controlled trial. Cd. Freiburg: Universität, [2023?], Freiburg: Universität, [2023?]. https://doi.org/10.1080/21645515.2019.1651141.

Zoulim, F., Fournier, C., Habersetzer, F., Sprinzl, M. F., Pol, S., Coffin, C. S., Leroy, V., Ma, M., Wedemeyer, H., Lohse, A. W., Thimme, R., Lugardon, K., Martin, P., Bastien, B., Sansas, B., Adda, N., Halluard, C., Bendjama, K., Brandely, M., & Inchauspé, G. (ca. 2023). Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1 b placebo-controlled trial [Cd]. Universität. https://doi.org/10.1080/21645515.2019.1651141

Zoulim, F., C. Fournier, F. Habersetzer, M. F. Sprinzl, S. Pol, C. S. Coffin, V. Leroy, M. Ma, H. Wedemeyer, A. W. Lohse, R. Thimme, K. Lugardon, P. Martin, B. Bastien, B. Sansas, N. Adda, C. Halluard, K. Bendjama, M. Brandely, und G. Inchauspé. Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1 b placebo-controlled trial. cd, Universität, 2023, https://doi.org/10.1080/21645515.2019.1651141.

ZOULIM, Fabien, Claire FOURNIER, François HABERSETZER, Martin F. SPRINZL, Stanislas POL, Carla S COFFIN, Vincent LEROY, Mang MA, Heiner WEDEMEYER, Ansgar W. LOHSE, Robert THIMME, Karine LUGARDON, Perrine MARTIN, Bérangère BASTIEN, Benoit SANSAS, Nathalie ADDA, Celine HALLUARD, Kaïdre BENDJAMA, Maud BRANDELY und Geneviève INCHAUSPÉ, 2023. Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1 b placebo-controlled trial. Freiburg: Universität